Hydroxyurea in the treatment of Churg-Strauss syndrome Rachel U. Lee, MD, Donald D. Stevenson, MD Journal of Allergy and Clinical Immunology Volume 124, Issue 5, Pages 1110-1111 (November 2009) DOI: 10.1016/j.jaci.2009.06.037 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Quantification of proteins of interest. Figures represent average spectral count values for patients between groups. Significant differences between 2 groups using the Benjamini-Hochberg false discovery rate procedure with false discovery rate=0.05 within each protein indicated by bracket endpoints over those columns. See Methods for statistical analysis details. A, e-fabp. B, α-Enolase. C, Triosephosphate isomerase. D, Serpin B3. E, Keratin 1 type II cytoskeletal 1. F, Dermcidin. Avg, Average; nonles., nonlesional. Journal of Allergy and Clinical Immunology 2009 124, 1110-1111DOI: (10.1016/j.jaci.2009.06.037) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions